Last 12 months
Inside the activity.
0 purchase rows · 59 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 13 |
| Dec 2025 | 0 | 3 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 15 |
| Mar 2026 | 0 | 4 |
| Apr 2026 | 0 | 3 |
| May 2026 | 0 | 5 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 1 |
| Aug 2026 | 0 | 7 |
| Sep 2026 | 0 | 3 |
| Oct 2026 | 0 | 2 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 03, 2025 Filed Jun 4, 2025 20:50 UTC |
COZADD BRUCE CDirector · Chairman & CEO
|
SaleOrdinary Shares | 500 | $110.00 | $55,000.00 |
DisclosureSEC source: 0001765581-25-000044 · edgardoc.xml · nonDerivative · entry 2 COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 437,973 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| June 02, 2025 Filed Jun 4, 2025 20:50 UTC |
COZADD BRUCE CDirector · Chairman & CEO
|
SaleOrdinary Shares | 500 | $107.90 | $53,950.00 |
DisclosureSEC source: 0001765581-25-000044 · edgardoc.xml · nonDerivative · entry 1 COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 438,473 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F2 · balance_after: The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025. Read SEC document |
| May 12, 2025 Filed May 13, 2025 22:51 UTC |
Mulligan SeamusDirector
|
PurchaseOrdinary Shares | 1,621 | $103.00 | $166,961.54 |
DisclosureSEC source: 0001765581-25-000042 · edgardoc.xml · nonDerivative · entry 4 Mulligan Seamus · CIK 0001536639 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Nerano Pharma Lim Disclosed balance after: 101,621 F4 · price: Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $102.97 to $103.00. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected. F2 · ownership.nature: Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family. Read SEC document |
| May 09, 2025 Filed May 13, 2025 22:51 UTC |
Mulligan SeamusDirector
|
PurchaseOrdinary Shares | 100 | $99.71 | $9,971.00 |
DisclosureSEC source: 0001765581-25-000042 · edgardoc.xml · nonDerivative · entry 3 Mulligan Seamus · CIK 0001536639 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Nerano Pharma Lim Disclosed balance after: 100,000 F2 · ownership.nature: Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family. Read SEC document |
| May 09, 2025 Filed May 13, 2025 22:51 UTC |
Mulligan SeamusDirector
|
PurchaseOrdinary Shares | 19,216 | $98.91 | $1,900,677.62 |
DisclosureSEC source: 0001765581-25-000042 · edgardoc.xml · nonDerivative · entry 2 Mulligan Seamus · CIK 0001536639 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Nerano Pharma Lim Disclosed balance after: 99,900 F3 · price: Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $98.56 to $99.47. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected. F2 · ownership.nature: Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family. Read SEC document |
| May 09, 2025 Filed May 13, 2025 22:51 UTC |
Mulligan SeamusDirector
|
PurchaseOrdinary Shares | 80,684 | $98.10 | $7,915,471.55 |
DisclosureSEC source: 0001765581-25-000042 · edgardoc.xml · nonDerivative · entry 1 Mulligan Seamus · CIK 0001536639 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · By Nerano Pharma Lim Disclosed balance after: 80,684 F1 · price: Reflects the purchase of ordinary shares executed in multiple transactions at prices ranging from $97.56 to $98.5542. The price reported reflects the weighted average purchase price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the purchases were effected. F2 · ownership.nature: Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family. Read SEC document |
| May 02, 2025 Filed May 5, 2025 23:00 UTC |
COZADD BRUCE CDirector · Chairman & CEO
|
SaleOrdinary Shares | 500 | $120.00 | $60,000.00 |
DisclosureSEC source: 0001765581-25-000039 · edgardoc.xml · nonDerivative · entry 2 COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 438,807 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| May 01, 2025 Filed May 5, 2025 23:00 UTC |
COZADD BRUCE CDirector · Chairman & CEO
|
SaleOrdinary Shares | 1,000 | $116.35 | $116,350.00 |
DisclosureSEC source: 0001765581-25-000039 · edgardoc.xml · nonDerivative · entry 1 COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 439,307 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| April 01, 2025 Filed Apr 3, 2025 21:32 UTC |
COZADD BRUCE CDirector · Chairman & CEO
|
SaleOrdinary Shares | 1,500 | $123.75 | $185,625.00 |
DisclosureSEC source: 0001765581-25-000037 · edgardoc.xml · nonDerivative · entry 1 COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 440,307 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| March 10, 2025 Filed Mar 11, 2025 22:17 UTC |
Carr PatriciaSVP, Chief Accounting Officer
|
SaleOrdinary Shares | 1,140 | $137.81 | $157,103.40 |
DisclosureSEC source: 0001765581-25-000031 · edgardoc.xml · nonDerivative · entry 2 Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,012 Read SEC document |
| March 10, 2025 Filed Mar 12, 2025 18:24 UTC |
Iannone RobertEVP, Global Head of R&D & CMO
|
SaleOrdinary Shares | 2,403 | $138.41 | $332,604.52 |
DisclosureSEC source: 0001765581-25-000035 · edgardoc.xml · nonDerivative · entry 1 Iannone Robert · CIK 0001737329 · EVP, Global Head of R&D & CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,621 Read SEC document |
| March 07, 2025 Filed Mar 7, 2025 23:49 UTC |
Iannone RobertEVP, Global Head of R&D & CMO
|
SaleOrdinary Shares | 1,548 | $140.00 | $216,720.00 |
DisclosureSEC source: 0001765581-25-000026 · edgardoc.xml · nonDerivative · entry 3 Iannone Robert · CIK 0001737329 · EVP, Global Head of R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,024 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| March 07, 2025 Filed Mar 7, 2025 23:49 UTC |
Iannone RobertEVP, Global Head of R&D & CMO
|
SaleOrdinary Shares | 5,532 | $138.21 | $764,577.72 |
DisclosureSEC source: 0001765581-25-000026 · edgardoc.xml · nonDerivative · entry 2 Iannone Robert · CIK 0001737329 · EVP, Global Head of R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 83,572 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. F3 · price: Reflects the sale of ordinary shares executed in multiple transactions at prices ranging from $138.19 to $138.23. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 22:19 UTC |
Henderson Mary ElizabethSVP, Technical Operations
|
Disposition to issuerOrdinary Shares | 698 | $138.23 | $96,484.54 |
DisclosureSEC source: 0001765581-25-000033 · edgardoc.xml · nonDerivative · entry 1 Henderson Mary Elizabeth · CIK 0001989533 · SVP, Technical Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,077 F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| March 07, 2025 Filed Mar 11, 2025 22:17 UTC |
Carr PatriciaSVP, Chief Accounting Officer
|
Disposition to issuerOrdinary Shares | 1,333 | $138.23 | $184,260.59 |
DisclosureSEC source: 0001765581-25-000031 · edgardoc.xml · nonDerivative · entry 1 Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,152 F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| March 05, 2025 Filed Mar 8, 2025 00:00 UTC |
Pearce SamanthaEVP, Chief Commercial Officer
|
Disposition to issuerOrdinary Shares | 1,905 | $138.95 | $264,699.75 |
DisclosureSEC source: 0001765581-25-000029 · edgardoc.xml · nonDerivative · entry 1 Pearce Samantha · CIK 0001805688 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 41,226 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 23:51 UTC |
Johnson Philip LEVP & Chief Financial Officer
|
Disposition to issuerOrdinary Shares | 1,149 | $138.95 | $159,653.55 |
DisclosureSEC source: 0001765581-25-000027 · edgardoc.xml · nonDerivative · entry 1 Johnson Philip L · CIK 0002013156 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,060 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 23:49 UTC |
Iannone RobertEVP, Global Head of R&D & CMO
|
Disposition to issuerOrdinary Shares | 5,239 | $138.95 | $727,959.05 |
DisclosureSEC source: 0001765581-25-000026 · edgardoc.xml · nonDerivative · entry 1 Iannone Robert · CIK 0001737329 · EVP, Global Head of R&D & CMO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,104 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 23:57 UTC |
Patil Neena MEVP & Chief Legal Officer
|
Disposition to issuerOrdinary Shares | 4,088 | $138.95 | $568,027.60 |
DisclosureSEC source: 0001765581-25-000028 · edgardoc.xml · nonDerivative · entry 1 Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 47,526 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 23:45 UTC |
GALA RENEE DPresident & COO
|
Disposition to issuerOrdinary Shares | 5,704 | $138.95 | $792,570.80 |
DisclosureSEC source: 0001765581-25-000025 · edgardoc.xml · nonDerivative · entry 1 GALA RENEE D · CIK 0001607737 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 88,895 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| March 05, 2025 Filed Mar 7, 2025 23:43 UTC |
COZADD BRUCE CDirector · Chairman & CEO
|
Disposition to issuerOrdinary Shares | 22,251 | $138.95 | $3,091,776.45 |
DisclosureSEC source: 0001765581-25-000024 · edgardoc.xml · nonDerivative · entry 1 COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 441,807 F1 · kind: Shares withheld to satisfy tax obligations arising out of vesting of a portion of previously granted restricted stock units. Read SEC document |
| March 03, 2025 Filed Mar 4, 2025 00:13 UTC |
COZADD BRUCE CDirector · Chairman & CEO
|
SaleOrdinary Shares | 6,500 | $144.25 | $937,625.00 |
DisclosureSEC source: 0001765581-25-000006 · edgardoc.xml · nonDerivative · entry 2 COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 464,058 F2 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| February 28, 2025 Filed Mar 4, 2025 00:21 UTC |
Carr PatriciaSVP, Chief Accounting Officer
|
SaleOrdinary Shares | 773 | $143.30 | $110,767.04 |
DisclosureSEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 8 Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,485 Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:35 UTC |
Pearce SamanthaEVP, Chief Commercial Officer
|
GrantOrdinary Shares | 5,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000016 · edgardoc.xml · nonDerivative · entry 2 Pearce Samantha · CIK 0001805688 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,131 F2 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:35 UTC |
Pearce SamanthaEVP, Chief Commercial Officer
|
GrantOrdinary Shares | 11,941 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000016 · edgardoc.xml · nonDerivative · entry 1 Pearce Samantha · CIK 0001805688 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 37,353 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:24 UTC |
Johnson Philip LEVP & Chief Financial Officer
|
GrantOrdinary Shares | 7,704 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000012 · edgardoc.xml · nonDerivative · entry 2 Johnson Philip L · CIK 0002013156 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,209 F3 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:24 UTC |
Johnson Philip LEVP & Chief Financial Officer
|
GrantOrdinary Shares | 15,407 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000012 · edgardoc.xml · nonDerivative · entry 1 Johnson Philip L · CIK 0002013156 · EVP & Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,505 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years. F2 · balance_after: The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 29, 2024. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 01:22 UTC |
Iannone RobertEVP, G R&D and CMO
|
GrantOrdinary Shares | 8,859 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000020 · edgardoc.xml · nonDerivative · entry 2 Iannone Robert · CIK 0001737329 · EVP, G R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,343 F2 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 01:22 UTC |
Iannone RobertEVP, G R&D and CMO
|
GrantOrdinary Shares | 17,718 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000020 · edgardoc.xml · nonDerivative · entry 1 Iannone Robert · CIK 0001737329 · EVP, G R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 85,484 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 01:19 UTC |
Henderson Mary ElizabethSVP, Technical Operations
|
GrantOrdinary Shares | 3,852 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000018 · edgardoc.xml · nonDerivative · entry 2 Henderson Mary Elizabeth · CIK 0001989533 · SVP, Technical Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,775 F2 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 01:19 UTC |
Henderson Mary ElizabethSVP, Technical Operations
|
GrantOrdinary Shares | 5,392 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000018 · edgardoc.xml · nonDerivative · entry 1 Henderson Mary Elizabeth · CIK 0001989533 · SVP, Technical Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 19,923 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:29 UTC |
GALA RENEE DPresident & COO
|
GrantOrdinary Shares | 11,555 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000014 · edgardoc.xml · nonDerivative · entry 2 GALA RENEE D · CIK 0001607737 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 94,599 F2 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:29 UTC |
GALA RENEE DPresident & COO
|
GrantOrdinary Shares | 23,111 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000014 · edgardoc.xml · nonDerivative · entry 1 GALA RENEE D · CIK 0001607737 · President & COO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 83,044 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:21 UTC |
Carr PatriciaSVP, Chief Accounting Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 313 | $0.00 Strike: $123.36 | $0.00 |
DisclosureSEC source: 0001765581-25-000010 · edgardoc.xml · derivative · entry 10 Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 313 shares Expires 2026-02-24 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F4 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 25, 2016, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The options were fully vested as of the date of exercise. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:21 UTC |
Carr PatriciaSVP, Chief Accounting Officer
|
Exercise / conversionNon-Qualified Stock Option (right to buy) · Derivative | 4,500 | $0.00 Strike: $113.10 | $0.00 |
DisclosureSEC source: 0001765581-25-000010 · edgardoc.xml · derivative · entry 9 Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 4,500 shares Expires 2030-02-26 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F3 · derivative.exercise_date: These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter. The options were fully vested as of the date of exercise. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:21 UTC |
Carr PatriciaSVP, Chief Accounting Officer
|
GrantOrdinary Shares | 2,889 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 7 Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,258 F2 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:21 UTC |
Carr PatriciaSVP, Chief Accounting Officer
|
Disposition to issuerOrdinary Shares | 497 | $142.43 | $70,788.11 |
DisclosureSEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 6 Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,369 F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:21 UTC |
Carr PatriciaSVP, Chief Accounting Officer
|
Disposition to issuerOrdinary Shares | 371 | $142.43 | $52,840.45 |
DisclosureSEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 5 Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 7,866 F1 · kind: Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:21 UTC |
Carr PatriciaSVP, Chief Accounting Officer
|
SaleOrdinary Shares | 313 | $144.42 | $45,202.27 |
DisclosureSEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 4 Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,237 Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:21 UTC |
Carr PatriciaSVP, Chief Accounting Officer
|
Exercise / conversionOrdinary Shares | 313 | $123.36 | $38,611.68 |
DisclosureSEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 3 Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,550 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:21 UTC |
Carr PatriciaSVP, Chief Accounting Officer
|
SaleOrdinary Shares | 4,500 | $144.42 | $649,872.90 |
DisclosureSEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 2 Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,237 Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:21 UTC |
Carr PatriciaSVP, Chief Accounting Officer
|
Exercise / conversionOrdinary Shares | 4,500 | $113.10 | $508,950.00 |
DisclosureSEC source: 0001765581-25-000010 · edgardoc.xml · nonDerivative · entry 1 Carr Patricia · CIK 0001784606 · SVP, Chief Accounting Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,737 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:18 UTC |
Patil Neena MEVP & Chief Legal Officer
|
GrantOrdinary Shares | 5,778 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000008 · edgardoc.xml · nonDerivative · entry 3 Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 51,614 F3 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on June 30, 2026. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:18 UTC |
Patil Neena MEVP & Chief Legal Officer
|
GrantOrdinary Shares | 12,518 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000008 · edgardoc.xml · nonDerivative · entry 2 Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 45,836 F2 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:18 UTC |
Patil Neena MEVP & Chief Legal Officer
|
SaleOrdinary Shares | 3,800 | $144.87 | $550,506.00 |
DisclosureSEC source: 0001765581-25-000008 · edgardoc.xml · nonDerivative · entry 1 Patil Neena M · CIK 0001783908 · EVP & Chief Legal Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,318 F1 · price: Reflects sales of ordinary shares executed in multiple transactions at prices ranging from $144.81 to $144.88. The price reported reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the Securities and Exchange Commission staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the sales were effected. Read SEC document |
| February 27, 2025 Filed Mar 4, 2025 00:13 UTC |
COZADD BRUCE CDirector · Chairman & CEO
|
GrantOrdinary Shares | 30,814 | $0.00 | $0.00 |
DisclosureSEC source: 0001765581-25-000006 · edgardoc.xml · nonDerivative · entry 1 COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 470,558 F1 · kind: These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units will vest in full on March 5, 2026. Read SEC document |
| February 03, 2025 Filed Feb 5, 2025 22:41 UTC |
COZADD BRUCE CDirector · Chairman & CEO
|
SaleOrdinary Shares | 1,500 | $122.31 | $183,465.00 |
DisclosureSEC source: 0001805688-25-000015 · edgardoc.xml · nonDerivative · entry 1 COZADD BRUCE C · CIK 0001193210 · Director · Chairman & CEO 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 439,744 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 23:40 UTC |
Pearce SamanthaEVP, Chief Commercial Officer
|
Tax withholdingOrdinary Shares | 1,365 | $122.62 | $167,376.30 |
DisclosureSEC source: 0001805688-25-000003 · edgardoc.xml · nonDerivative · entry 2 Pearce Samantha · CIK 0001805688 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 25,412 F3 · kind: Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 23:40 UTC |
Pearce SamanthaEVP, Chief Commercial Officer
|
GrantOrdinary Shares | 2,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001805688-25-000003 · edgardoc.xml · nonDerivative · entry 1 Pearce Samantha · CIK 0001805688 · EVP, Chief Commercial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 26,777 F1 · kind: Represents ordinary shares of Jazz Pharamceuticals that will be delivered pursuant to the terms of performance share awards made to the reporting person on March 3, 2022. The performance-based vesting requirements applicable to such awards were satisfied on January 17, 2025, which represents the date on which the level of performance attained was certified. F2 · balance_after: The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on November 29, 2024. Read SEC document |
| January 17, 2025 Filed Jan 22, 2025 23:58 UTC |
Iannone RobertEVP, G R&D and CMO
|
Tax withholdingOrdinary Shares | 2,181 | $122.62 | $267,434.22 |
DisclosureSEC source: 0001805688-25-000013 · edgardoc.xml · nonDerivative · entry 2 Iannone Robert · CIK 0001737329 · EVP, G R&D and CMO 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,766 F3 · kind: Shares to be withheld from the vesting and distribution of performance award shares to satisfy the reporting person's tax obligations. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.